Fig. 3From: A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohortDetectable hazard ratio according to the number of events for different levels of exposure prevalenceBack to article page